Differences in anthropometric and ultrasonographic parameters between adolescent girls with regular and irregular menstrual cycles: a case-study of 835 cases.

Study Objective: Exploring the relation between the age, time since menarche, anthropometric parameters and the growth of the uterus and ovaries in postmenarcheal girls.

Design: Cross sectional.

Setting: Department of Human reproduction at a tertiary pediatric referral center.

Tibolone: the way to beat many a postmenopausal ailments.

Objective: The effects of tibolone on climacteric symptoms, osteoporosis, cardiovascular disease, breasts and the endometrium are summarised, and its role in clinical practice is reviewed in this article.

Background: Tibolone has tissue-specific effects on receptors and enzymes that influence the synthesis and metabolism of endogenous sexual steroid hormones.

Methods: This evaluation was based on the findings from several randomised studies, which addressed the basic and clinical research on tibolone.

Influence of adiposity on leptin, LH and androgen levels in lean, overweight and obese PCOS patients.

Background: Leptin modulates hypothalamic-pituitary-gohadal axis functions.

Objective: To assess the influence of leptin on LH, and to investigate the potential association of leptin with body mass index (BMI) and androgen concentrations in women with polycystic ovary syndrome (PCOS).

Design: Levels of leptin, LH, FSH, E2, testosterone, and androstenedione were measured.

The most frequent hormone dysfunctions in juvenile bleeding.

The main goal of this study was to investigate the precise hormone dysfunction that leads to dysfunctional uterine bleeding (DUB) in adolescent girls so that, with the appropriate therapy, the occurrence of organic dysfunctions of their reproductive function can be prevented. This study included 70 adolescents with DUB aged 14.70 +/- 1.

Tibolone and osteoporosis.

Background: We conducted a 5-year prospective, observational, controlled study to assess the effects of tibolone 1.25 mg/day on bone mineral density (BMD) in postmenopausal women with osteopenia or osteoporosis.

Methods: The subjects were 420 women, an average of 66.